455 results on '"Blin, Patrick"'
Search Results
2. Strong instrumental variables biased propensity scores in comparative effectiveness research: A case study in oncology
3. Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires, substitutives, ou les seules sources de données par rapport aux essais cliniques ?
4. National Health Insurance Claims Database in France (SNIRAM), Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH)
5. Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
6. Design and validation of algorithms to identify venous thromboembolism in the French National Healthcare Database
7. Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database
8. The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France
9. NSAIDs and COVID-19: A Systematic Review and Meta-analysis
10. Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database
11. Pharmacoepidemiology
12. Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data
13. Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database
14. Pharmacovigilance – The next chapter
15. Does Ibuprofen Worsen COVID-19?
16. Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
17. Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI
18. National Health Insurance Claims Database in France (SNIRAM), Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH)
19. Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
20. Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database
21. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database
22. Risk of cancer with immunosuppressants compared to immunomodulators in multiple sclerosis: A nested case–control study within the French nationwide claims database
23. Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study
24. Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
25. Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study
26. Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study
27. Impact of a public media event on the use of statins in the French population
28. Pharmacoepidemiology
29. Design and validation of algorithms to identify Venous Thromboembolism in the French National Healthcare Database
30. Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis
31. Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation: A Population-Based New Users High-Dimensional Propensity Score Matched Cohorts Study
32. Clustering of prostate cancer healthcare pathways in the French National Healthcare database
33. Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
34. High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting
35. Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database
36. Abstract 20559: Effectiveness and Safety of Rivaroxaban 15 mg Compared With Vitamin K Antagonists in Very Elderly Patients With Atrial Fibrillation, a Matched Cohort Study in the French Nationwide Claims Database SNIIRAM
37. Relative Risks from Case-Population Data
38. An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
39. Pharmacoepidemiology Studies: what Levels of Evidence and how can They be Reached?
40. Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
41. Is paracetamol ever safe?
42. Outcomes in patients after myocardial infarction similar to those of the PEGASUS‐TIMI 54 trial: A cohort study in the French national claims database
43. High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.
44. Apport de la modélisation et des populations virtuelles pour transposer les résultats des essais cliniques à la vie réelle et éclairer la décision publique
45. Contribution of Modeling Approaches and Virtual Populations in Transposing the Results of Clinical Trials into Real Life and in Enlightening Public Health Decisions
46. Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) Database
47. Impact of Prescriber Nonresponse on Patient Representativeness
48. How to Improve the Clinical Development Paradigm and its Division into Phases I, II and III
49. Comment faire évoluer le paradigme du développement clinique et son découpage en phases I, II, III
50. Incidence and risk of cancer among multiple sclerosis patients: A matched population‐based cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.